Grants / Department of Health and Human Services / National Institutes of Health

PAR-24-206: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)

Closed Closed August 19, 2024 Opportunity PAR-24-206 ☆ Save

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2024.

• Award ceiling$1.0 million
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

• Projects NIH funded under this notice had a median yearly award of $248,194; it allows up to $1.0 million per award.
• Most of the money in the 13 programs behind this notice (71% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The objective of this Notice of Funding Opportunity (NOFO) is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The RDCRCs are intended to advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational and clinical research. Special emphasis will be placed on the early and timely identification of individuals with rare diseases and clinical trial readiness.

Category: Food and Nutrition, Health, Income Security and Social Services.

Other programs behind this notice

• Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847
  $9.6 billion in five years
• Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853
  $9.1 billion in five years
• Child Health and Human Development Extramural Research 93.865
  $6.0 billion in five years
• National Center for Advancing Translational Sciences 93.350
  $3.1 billion in five years
• Arthritis, Musculoskeletal and Skin Diseases Research 93.846
  $2.6 billion in five years
• Human Genome Research 93.172
  $2.2 billion in five years
• Research Related to Deafness and Communication Disorders 93.173
  $2.1 billion in five years
• Oral Diseases and Disorders Research 93.121
  $1.9 billion in five years
• Lung Diseases Research 93.838
  $8.7 million in five years
• Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders 93.840
  $3.3 million in five years

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.